Webinar: Non-Viral Manufacturing of Gene Modified CAR-T Therapies Using TcBuster™
Webinar Summary
Mitigate risk and embed flexibility into your immune cell therapy workflow.
This webinar presents a technical talk focusing on how gene modified cell therapies can be manufactured at scale using the TcBuster™ transposon system, specialty media, and liquid cytokines. It also describes how automated Simple Plex™ assays on Ella™ can be used for the functional assessment of CAR-T cells.
For additional insights on the TcBuster system, read the Lentiviral vs. Non-Viral Gene Transfer for CAR-T Manufacturing Application Note.
Up Next